1 – 2 of 2
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.
(
- Contribution to journal › Article
- 2006
-
Mark
Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.
(
- Contribution to journal › Article